Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders (French, HTML)

View metadata and access the original French HTML file: Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-27

The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021.

Access original file